Clinical Trial Update: A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Administering Multiple Oral Doses of GSK1292263 Alone and With Atorvastatin [Phase 2]

View source ↗

Summary

Phase 2 study evaluating safety, tolerability, pharmacokinetics and pharmacodynamics of multiple oral doses of GSK1292263 alone and with atorvastatin in dyslipi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemias

Drugs mentioned

• GSK1292263
• atorvastatin (atorvastatin)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Dyslipidaemias, Dyslipidemias | Phase 2 | Status: COMPLETED | Results posted: 2017-11-08